Post by
stockbuphoon on Jun 19, 2021 11:46pm
Ad hominem
You think that Thomson is a swing day trader like you and is not burying 4050? Guess you made lots of money on the $7 to $4 short over the last week? Thomson took years to decide on next phase 2 candidate of 4050 as IPF when markets for kidney and liver were huge and results strong - as in "penicillin" as quoted by Laurin and Moran. So, you're saying they lied and Pritchard is telling the truth? Ryplazim? They spent $100's of millions for $70M from PRV and $5M for plasma division which include IVIG and many others. Sure, kid. Can you quote anything from foundational value argument of any analyst? Didn't think so..
Comment by
realstocky on Jun 19, 2021 11:51pm
This post has been removed in accordance with Community Policy